Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Akari Therapeutics (AKTX) shares
Learn how to easily invest in Akari Therapeutics shares.
Akari Therapeutics is a biotechnology business based in the US. Akari Therapeutics stocks (AKTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.63 – a decrease of 3.45% over the previous week. Akari Therapeutics employs 9 staff and has a market cap (total outstanding stock value) of $74.2 million.
How to buy shares in Akari Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AKTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Akari Therapeutics?
- Has coronavirus impacted Akari Therapeutics shares?
- Akari Therapeutics shares summary
- Compare share dealing platforms
- Is Akari Therapeutics stock a buy or sell?
- Akari Therapeutics performance over time
- Akari Therapeutics's financials
- How volatile are Akari Therapeutics shares?
- Does Akari Therapeutics pay a dividend?
- Have Akari Therapeutics shares ever split?
- Other common questions
Akari Therapeutics stock price (NASDAQ:AKTX)Use our graph to track the performance of AKTX stocks over time.
Akari Therapeutics shares at a glance
|Latest market close||$1.40|
|52-week range||$1.29 - $4.21|
|50-day moving average||$1.53|
|200-day moving average||$1.72|
|Wall St. target price||$5.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.49|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Akari Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Akari Therapeutics price performance over time
|1 week (2022-01-21)||-2.10%|
|1 month (2021-12-28)||-6.04%|
|3 months (2021-10-28)||-17.65%|
|6 months (2021-07-28)||-14.11%|
|1 year (2021-01-28)||-41.67%|
|2 years (2020-01-28)||-24.32%|
|3 years (2019-01-28)||2|
|5 years (2017-01-24)||6.8|
Akari Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-80.24%|
|Return on equity TTM||-227.43%|
|Market capitalisation||$74.2 million|
TTM: trailing 12 months
Akari Therapeutics share dividends
We're not expecting Akari Therapeutics to pay a dividend over the next 12 months.
Have Akari Therapeutics's shares ever split?
Akari Therapeutics's shares were split on a 1:10 basis on 16 September 2015. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Akari Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Akari Therapeutics shares which in turn could have impacted Akari Therapeutics's share price.
Akari Therapeutics share price volatility
Over the last 12 months, Akari Therapeutics's shares have ranged in value from as little as $1.29 up to $4.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akari Therapeutics's is 1.2681. This would suggest that Akari Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Akari Therapeutics overview
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory diseases that involve complement and leukotriene pathways. Its lead product candidate is nomacopan, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom. .
Akari Therapeutics in the news
Akari Therapeutics : Advances Lung Program with Inhaled Nomacopan Focused on Early Treatment of Severe Exacerbations in Lung Diseases - Form 6-K
Akari Advances Lung Program with Inhaled Nomacopan Focused on Early Treatment of Severe Exacerbations in Lung Diseases
Akari Therapeutics advances lung program with inhaled nomacopan
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.